PharmaRadar360 guides
Pharma regulatory guides
Plain-language explainers on drug approval pathways, regulators, clinical trial records and rare-disease incentives, written from official sources.
Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review: FDA’s expedited programs explained
How FDA’s four expedited programs differ: who qualifies, when sponsors ask, how fast FDA answers, and what each one does and does not change about approval.
· 8 min read
How to check whether a drug is approved: FDA, EMA, MHRA, PMDA, NMPA and Health Canada
Which official database to open for each major regulator, what each one shows, and the common traps that make a drug look approved when it is not.
· 7 min read
Guides are general information for professionals and are not legal, regulatory or medical advice.